The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500 · cited 2×
“Trastuzumab, when given in combination with paclitaxel, achieved a survival benefit of 5 months compared with single-agent treatment of paclitaxel [14].”
BackgroundCobleigh, M. A., Vogel, C. L., Tripathy, D., Robert, N. J., Scholl, S., Fehrenbacher, L., Wolter, J. M., Paton, V., Shak, S., Lieberman, G., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2639 · Cited by 2,765
Press, M. F., Hung, G., Godolphin, W. J., & Slamon, D. (1994) · PubMed · Cited by 478
Kuukasjärvi, T., Karhu, R., Tanner, M., Kähkönen, M., Schäffer, A. A., Nupponen, N. N., Pennanen, S., Kallioniemi, A. H., Kallioniemi, O., & Isola, J. (1997) · PubMed · Cited by 401
Kuukasjärvi, T., Kononen, J., Helin, H., Holli, K., & Isola, J. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.9.2584 · Cited by 358
Tsuda, H., Hirohashi, S., Shimosato, Y., Hirota, T., Tsugane, S., Yamamoto, H., Miyajima, N., Toyoshima, K., Yamamoto, T. S., & Yokota, J. (1989) · PubMed · Cited by 341
Genetic alterations in breast cancer
Bièche, I., & Lidereau, R. (1995) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870140402 · Cited by 303
Patterns of HER-2/neu Amplification and Overexpression in Primary and Metastatic Breast Cancer
Simon, R., Nocito, A., Hubscher, T., Bucher, C., Torhorst, J., Schraml, P., Bubendorf, L., Mihatsch, M. M., Moch, H., Wilber, K., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.15.1141 · Cited by 290
HER-2/neu (c-erb-B2) gene and protein in breast cancer.
Ross, J. S., & Fletcher, J. A. (1999) · PubMed · Cited by 267
Amplification of HER-2/neu and topoisomerase IIalpha in primary and metastatic breast cancer.
Tanner, M., Järvinen, P., & Isola, J. J. (2001) · PubMed · Cited by 215
Growth Dominance of the Metastatic Cancer Cell: Cellular and Molecular Aspects
(1990) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60469-8 · Cited by 178
Lacroix, H., Iglehart, J. D., Skinner, M. A., & Kraus, M. H. (1989) · PubMed · Cited by 162
Breast cancer heterogeneity: Evaluation of clonality in primary and metastatic lesions
Symmans, W. F., Liu, J., Knowles, D. M., & Inghirami, G. (1995) · Human Pathology · doi:10.1016/0046-8177(95)90039-x · Cited by 93
Teixeira, M. R., Pandis, N., Bardi, G., et al. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910630113 · Cited by 83
Gancberg, D., Järvinen, T. A. H., Leo, A. D., Rouas, G., Cardoso, F., Paesmans, M., Verhest, A. P., Piccart, M. J., Isola, J. J., & Larsimont, D. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1016146130767 · Cited by 70
Self-citation
Cited by
AACR Centennial Series: The Biology of Cancer Metastasis: Historical Perspective
Talmadge, J. E., & Fidler, I. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1040 · Cited by 1,169
Desmedt, C., Piette, F., Loi, S., Wang, Y., Lallemand, F., Haibe-Kains, B., Viale, G., Delorenzi, M., Zhang, Y., d'Assignies, M. S., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2765 · Cited by 968
Self-citationSelective molecular imaging of viable cancer cells with pH-activatable fluorescence probes
Urano, Y., Asanuma, D., Hama, Y., Koyama, Y., Barrett, T., Kamiya, M., Nagano, T., Watanabe, T., Hasegawa, A., Choyke, P. L., et al. (2009) · Nature Medicine · doi:10.1038/nm.1854 · Cited by 801
Tumor Imaging Using a Picomolar Affinity HER2 Binding Affibody Molecule
Orlova, A., Magnusson, M., Eriksson, T. L. J., Nilsson, M., Larsson, B., Höidén-Guthenberg, I., Widström, C., Carlsson, J., Tolmachev, V., Ståhl, S., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3521 · Cited by 568
HER-2 gene amplification can be acquired as breast cancer progresses
Meng, S., Tripathy, D., Shete, S., Ashfaq, R., Haley, B., Perkins, S., Beitsch, P., Khan, A., Euhus, D., Osborne, C., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402993101 · Cited by 508
Metadata
- Authors
- Gancberg, D., Di Leo, A., Cardoso, F., Rouas, G., Pedrocchi, M., Paesmans, M., Verhest, A., Bernard-Marty, C., Piccart, M. J., & Larsimont, D.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2002-07
- Volume
- 13
- Issue
- 7
- Pages
- 1036-1043
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2129134252
- Cited by
- 309
- References
- 16
- FWCI
- 5.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.